No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Tempus AI Chairman and CEO Eric Lefkofsky Sells $62M of Shares
Investors Appear Satisfied With Tempus AI, Inc.'s (NASDAQ:TEM) Prospects As Shares Rocket 48%
Genialis Advances Biomarker Discovery to Reduce Risk in Cancer Drug Development Targeting DNA Damage Response Pathways
Tempus AI Stock Before Q4 Earnings: To Buy or Not to Buy?
Tempus AI Insider Sold Shares Worth $62,023,231, According to a Recent SEC Filing
Stargate Project's Healthcare Winners: AI-led Biotechs and Metagenomi